AstraZeneca (LSE:AZN)
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
About
Last updated 13-05-2021, 03:03:22pm BSTRelated Articles
-
GlaxoSmithKline shares: why I’m not buying
GlaxoSmithKline has been popular with investors for decades. Despite this, Dan Peeke is wary of investing in the pharmaceutical giant. Read More »
-
AstraZeneca stock: time to sell?
Looking beyond the company’s vaccine woes, is now the time to make the most of the uptick in AstraZeneca stock and sell out? Read More »
-
The AstraZeneca share price is rising fast. Here’s what I’d do now
The AstraZeneca share price is rising fast after its robust results. But can it rise much further from its already elevated levels? Read More »
-
ESG investing: which UK companies might I invest in?
A look at ESG investing and two UK FTSE 100 companies with strong ESG credentials, which might make them appealing to future investors. Read More »
-
Novacyt or AstraZeneca: which biotech stock should I buy?
Novacyt and AstraZeneca are two biotech stocks working in the realms of fighting the Covid-19 pandemic. Are either good long-term investments? Read More »
-
3 reasons to buy the FTSE 100’s AstraZeneca stock now
Here's why I'd be keen to get a solid-looking business such as AstraZeneca into my long-term diversified portfolio right now. Read More »
-
Is the AstraZeneca share price undervalued?
The AstraZeneca share price has been falling since last summer. Roland Head is starting to see a potential buying opportunity. Read More »
-
As the AstraZeneca share price slides, I’d buy
The AstraZeneca share price has been under pressure due to temporary headwinds, but these will not last forever and growth will return. Read More »
-
2 unloved FTSE 100 stocks I’d buy before it’s too late
With the FTSE 100 rising recently, one Fool looks at two companies that have been left behind and why this could represent a good... Read More »
-
These are 2 of my top stocks to buy in April
These are Manika Premsingh's two top stocks because of their strong credentials combined with their current subdued share prices. Read More »